Patent 10085861 was granted and assigned to Boston Scientific on October, 2018 by the United States Patent and Trademark Office.
The present invention relates to an endoluminal device for implantation in a body lumen, such as a pancreatic duct. The device is provided with a distal end region having greater flexibility than that of a medial region of the device.